Metraipolis › archive › dc_e59491ed41bf
Unique cellular immune signatures of multisystem inflammatory syndrome in children — Europe PMC PMID:36322537
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/36322537
- DOI
- 10.1371/journal.ppat.1010915
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-15T23:11:15.617Z
- SHA-256 of the archived text
0a6ef8bd5a3f93c9106d05eba12d8bfa5d46b92c4e289cc78f85e19c7b09272e- Stable URL of this page
https://metraipolis.com/documento/dc_e59491ed41bf
How to cite
Unique cellular immune signatures of multisystem inflammatory syndrome in children — Europe PMC PMID:36322537 — Europe PMC (en), https://europepmc.org/article/MED/36322537 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_e59491ed41bf (Metraipolis archive dc_e59491ed41bf, sha256 0a6ef8bd5a3f93c9106d05eba12d8bfa5d46b92c4e289cc78f85e19c7b09272e)
BibTeX
@misc{dce59491ed41bf,
title = {Unique cellular immune signatures of multisystem inflammatory syndrome in children — Europe PMC PMID:36322537},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/36322537},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_e59491ed41bf; sha256 0a6ef8bd5a3f93c9106d05eba12d8bfa5d46b92c4e289cc78f85e19c7b09272e},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36322537. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
The clinical presentation of MIS-C overlaps with other infectious/non-infectious diseases such as acute COVID-19, Kawasaki disease, acute dengue, enteric fever, and systemic lupus erythematosus. We examined the ex-vivo cellular parameters with the aim of distinguishing MIS-C from other syndromes with overlapping clinical presentations. MIS-C children differed from children with non-MIS-C conditions by having increased numbers of naïve CD8+ T cells, naïve, immature and atypical memory B cells and diminished numbers of transitional memory, stem cell memory, central and effector memory CD4+ and CD8+ T cells, classical, activated memory B and plasma cells and monocyte (intermediate and non-classical) and dendritic cell (plasmacytoid and myeloid) subsets. All of the above alterations were significantly reversed at 6-9 months post-recovery in MIS-C. Thus, MIS-C is characterized by a distinct cellular signature that distinguishes it from other syndromes with overlapping clinical presentations. Trial Registration: ClinicalTrials.gov clinicaltrial.gov. No: NCT04844242. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS pathogens, 2022 (prima pubblicazione 2022-11-02). Identificativi: PMID 36322537 · PMCID PMC9629618 · DOI 10.1371/journal.ppat.1010915. Descrittori MeSH principali: Lupus Erythematosus, Systemic; COVID-19. Pagina: https://europepmc.org/article/MED/36322537 — https://doi.org/10.1371/journal.ppat.1010915. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-15T22:44:19.539Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.